Loading...
Loading...
Medical imaging (X-ray, CT, MRI), electronic health records, clinical trials, ECG/EEG, pathology
13,085 datasets
Yaohui Liu published a clinical trial report on figshare in March 2026. The dataset describes a randomized controlled trial involving 152 ICU patients with sepsis, investigating the effect of early Shenfu Injection administration on preventing sepsis-induced cardiomyopathy. The primary outcome was the incidence of SIC within 7 days, with secondary measures including NT-proBNP levels, hemodynamic parameters, and 28-day mortality.
A dataset from a randomized controlled trial evaluating the early administration of Shenfu Injection for preventing sepsis-induced cardiomyopathy. The trial analyzed 152 patients in an ICU setting, with primary outcomes measured over 7 days. The data was published by Yaohui Liu on figshare in March 2026.
A single-center clinical study of 29 patients aged 60 years and older with newly diagnosed acute myeloid leukemia (AML). The dataset, authored by Juan Liu and last updated in March 2026, contains results from a long-term follow-up with a median of 148.5 months, tracking outcomes like complete remission, overall survival, and relapse rates for patients treated with microtransplantation between April 2008 and June 2021.
A single-center clinical study of 29 patients aged 60 and over with newly diagnosed acute myeloid leukemia (AML) treated with microtransplantation between April 2008 and June 2021. The dataset includes endpoints such as complete remission rates, overall survival, leukemia-free survival, relapse, and non-relapse mortality, with a median follow-up of 148.5 months. The data was published by Juan Liu under a CC-BY-4.0 license.
Juan Liu's dataset contains clinical results from a single-center study of 29 patients aged 60 years or older with newly diagnosed acute myeloid leukemia (AML). The data covers patients treated with microtransplantation between April 2008 and June 2021, with a median follow-up of 148.5 months. It includes endpoints such as complete remission rates, overall survival, leukemia-free survival, relapse incidence, and safety outcomes.
Table 2_Microtransplantation improves the outcome of older patients with newly diagnosed acute myeloid leukemia: a single-center study with long-term follow-up.xls contains clinical trial data from a single-center study. The study involved 29 patients aged 60 and over, treated between April 2008 and June 2021, with a median follow-up of 148.5 months. The dataset, authored by Juan Liu and shared under a CC-BY-4.0 license, includes endpoints such as complete remission, overall survival, and leukemia-free survival.
Between April 2008 and June 2021, a single-center study of 29 patients aged 60 and over with newly diagnosed acute myeloid leukemia (AML) received microtransplantation therapy. The dataset includes endpoints such as complete remission rates, overall survival, leukemia-free survival, and safety outcomes, with a median follow-up of 148.5 months. Author Juan Liu published the data under a CC-BY-4.0 license.
A UK-based cross-sectional survey of 292 healthcare workers recruited via Prolific. The dataset likely contains responses measuring digital job demands, resources like autonomy and resilience, and well-being outcomes such as job satisfaction and thriving at work. The data was collected by Parisa Afshin and last updated on 2026-03 18.
292 healthcare workers in the UK were surveyed via Prolific to examine relationships between digital job demands, resources, and workplace well-being. The dataset contains survey results analyzed using structural equation modeling in R. It was authored by Parisa Afshin and last updated in March 2026.
2,675 patient records from a retrospective cohort study of ST-elevation myocardial infarction survivors admitted between January 2014 and December 2021. Guangze Xiang published this data on figshare in 2026, showing a mean follow-up period of 1,013 days. The analysis links low Albumin-to-D-dimer ratio levels to higher rates of all-cause mortality and new-onset stroke after hospital discharge.
Seven studies comprising 15,228 participants receiving SGLT inhibitors and 12,736 receiving placebo were analyzed in this systematic review. The meta-analysis, conducted by Zhenlin Zhang and published on figshare in 2026, found a 53% reduction in chronic kidney disease composite outcomes. The review included literature from MEDLINE, Embase, and Cochrane databases up to January 1, 2025.
A prospective cohort study investigating the predictive value of circulating biomarkers for stroke-associated pneumonia in patients with acute anterior circulation large vessel occlusion following endovascular therapy. The dataset includes measurements of monocyte HLA-DR, interleukin-6, C-reactive protein, and procalcitonin taken on days 1, 3, and 7 post-procedure. It was authored by Yongsen Lin and last updated on 2026-03-18.
265 patients with a median age of 63.5 years were included in this systematic review evaluating thalidomide for gastrointestinal bleeding from angiodysplasia. The document, authored by Junaid Khan and last updated in March 2026, synthesizes evidence from six clinical studies published between 1994 and 2024. It reports on clinical outcomes, response rates, and adverse effects associated with thalidomide treatment.
94.44% of 18 esophageal squamous cell carcinoma (ESCC) samples showed TP53 mutations via whole-exome and whole-genome sequencing. The dataset, published by Xueyu Zhuang in 2026, compares these genetic mutations with mutant p53 protein expression detected by immunohistochemistry. It reports a 100% sensitivity and specificity for mutant p53 expression in diagnosing ESCC across 78 total patient samples.
258 breast ultrasound examinations (129 malignant, 129 benign) were interpreted by six radiologists with and without AI assistance. Hyuksool Kwon published the study on figshare in March 2026. Vis-BUS AI assistance modestly increased the pooled AUROC from 0.921 to 0.953 and halved the median interpretation time from 6.0 to 3.0 seconds.
Data Sheet 1_Medical interns and health challenges contains longitudinal observational data on 170 medical interns (18–25 years) from a Mexican public university hospital, assessed at baseline and after 12 months. The dataset includes anthropometric and body composition parameters from bioimpedance analysis, physical activity levels from the GPAQ, and sleep quality scores from the PSQI. It was authored by Ricardo Salas-Flores and last updated on 2026-03-18.
A longitudinal observational study of 170 medical interns (18–25 years) at a Mexican public university hospital, assessed at baseline and after 12 months. The dataset includes anthropometric and body composition parameters, physical activity levels, and sleep quality scores. It was authored by Ricardo Salas-Flores and last updated on 2026-03-18.
A one-year longitudinal study of 170 medical interns aged 18–25 at a Mexican public university hospital, assessed at baseline and after 12 months. The dataset, authored by Ricardo Salas-Flores and last updated in March 2026, likely contains anthropometric, body composition, physical activity, and sleep quality measurements. It was collected using bioimpedance analysis, the Global Physical Activity Questionnaire, and the Pittsburgh Sleep Quality Index.
170 medical interns at a Mexican public university hospital were assessed for changes in body composition, physical activity, and sleep quality over a 12-month period. The study, authored by Ricardo Salas-Flores and last updated in March 2026, reports a mean BMI increase from 25.47 to 26.22 kg/m² and a deterioration in overall sleep quality among participants.
A 2026 study of 152 patients with acute COVID-19 in central China, where 54.6% had co-existing respiratory pathogen infections. The data includes clinical characteristics, hospitalization days, severity classification, outcomes, and laboratory results like white blood cell count and D-dimer. It was authored by Yiman Geng and shared on figshare under a CC-BY-4.0 license.